Navigation Links
Men Might Get Their Share of Cervical Cancer Vaccine As Well

The first ever-cervical cancer vaccine, Gardasil is expected to be launched in New Zealand soon, targeting females between 9 and 24 years of age. // Soon, men might also be given cervical cancer vaccines to prevent them from infecting their sexual partners and to protect themselves against several diseases.

The vaccine is currently under experimental phase, for demonstration of cervical cancer prevention. Most cases of cervical cancer can be attributed to human papilloma virus infection (HPV), spread through sexual contact. An association between the virus and anal cancer has also been observed, consistent with high reports of infection among gay men.

Previous vaccine trials had demonstrated the increase in antibody production against the four target HPV types, known to cause cancer and genital warts in both men and women. There could be a 70% reduction in the cervical cancer incidence if the vaccine is found to be effective in preventing HPV associated cervical cancers.

It has been found form numerous studies that 80% of the population is exposed to HPV at some point during their lifetime. A majority of this goes unnoticed, as there are no symptoms. The immune system may be effective in getting rid of the virus. A small group of people however develop persistent infections.

The effectiveness of the vaccine would be more relevant when it is administered before onset of sexual activity. Taking this fact into account, the ideal age for administration of the vaccine is considered to be 11 years. If approved for use, it can be incorporated as the last of injections on the national immunization schedule.

Cervical cancer represents a major health care burden haunting women. This may be the focus for increased clinical trials in women when compared to the poor attention given to prevention of HPV-linked cancers in men. However, large clinical trials involving men are being conducted, the results of which would be released in three years time.

In line with these clinical trials, GlaxoSmithKline is also testing a potential HPV vaccine. With such healthy competition among several pharmaceutical companies, we might perhaps soon put an end to the misery and suffering associated with at least one form of cancer.


'"/>




Related medicine news :

1. Anemia Treatment for Cancer Patients Might Not be a Good Idea.
2. Tomatoes Might Inhibit the Development Of Prostate Cancer
3. Mad Cow Disease Might Be Linked to Blood Transfusions
4. Strategies That Might Lower Blood Pressure Questioned
5. Factors That Might Increase The Risk Of Schizophrenia
6. A Drug That Might Relieve Chronic Cough
7. Biochemical Markers Might Help Predict Heart Problems
8. Yoga Might Be Helpful For Cancer Patients
9. Healthcare Professionals Might Want To Rethink Their Dress Code
10. Embryonic Cells Might Prevent Parkinson’s Disease From Worsenin
11. Counting Calories Might Be The Ideal Way To Stay Healthy
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2017)... ... April 26, 2017 , ... ... agile ecosystem and domain expertise for sponsors and CROs to speed clinical ... supply management (RTSM) software platform. Bioclinica AGILE RTSM provides seamless ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... Beach, California, committed to raising awareness for Duchenne muscular dystrophy, and funding ... randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced ...
(Date:4/25/2017)... ... April 25, 2017 , ... Lake Park Dental is now accepting new ... in Lutz, FL. With the help of this highly-effective, yet convenient system, patients ... complications, more discretion and less pain. , Drs. Sarah Jockin, Nicole Morganti, Sara ...
(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in the thriving ... and head shops –can’t help but be heartened by the industry’s current surge. But ... aptly described as “skunk smell.” At last they can simply, safely and effectively ...
(Date:4/25/2017)... ... 25, 2017 , ... Vetoquinol USA® , a world-class ... part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in ... immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair of ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
(Date:4/18/2017)... 2017  Cardinal Health (NYSE: CAH ) ... earnings per share (EPS) guidance and providing a preliminary ... conjunction with this morning,s announcement of the planned acquisition ... Insufficiency businesses. Cardinal Health now believes that ... at the bottom of its previous guidance range of ...
(Date:4/18/2017)... , April 18, 2017  Astute Medical, Inc., developer ... series to be presented at the 2017 National Kidney ... today and continues through April 22. Physicians will present ... used to assess risk for acute kidney injury (AKI) ... failure (ADHF). Elevated levels of TIMP-2 ...
Breaking Medicine Technology: